Related references
Note: Only part of the references are listed.Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Heli Julkunen et al.
NATURE COMMUNICATIONS (2023)
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis Distinguishing Between Particle Concentration, Type, and Content
Nicholas A. Marston et al.
JAMA CARDIOLOGY (2022)
Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform - Focus on LDL subclasses
Ronald M. Krauss et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2022)
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Hiroaki Ikezaki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G. Richardson et al.
PLOS MEDICINE (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease Data From UK Biobank
Claire Welsh et al.
CIRCULATION (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Phlebotomy tube interference with nuclear magnetic resonance (NMR) lipoprotein subclass analysis
Laura L. Needham et al.
CLINICA CHIMICA ACTA (2019)
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
Michael V. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
Anum Saeed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Low-Density Lipoprotein Triglycerides Widening the Atherogenic Landscape in CVD Risk Assessment
Michael Miller
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population
Anna Fry et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
Parag H. Joshi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
Samia Mora et al.
CIRCULATION (2014)
High-Density Lipoprotein Particle Subclass Heterogeneity and Incident Coronary Heart Disease
Akintunde O. Akinkuolie et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do et al.
NATURE GENETICS (2013)
Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study
Allan D. Sniderman et al.
ATHEROSCLEROSIS (2012)
Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
Sarah Parish et al.
CIRCULATION (2012)
Small dense LDL: An emerging risk factor for cardiovascular disease
Satoshi Hirayama et al.
CLINICA CHIMICA ACTA (2012)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui et al.
ANNALS OF INTERNAL MEDICINE (2009)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Samia Mora et al.
CIRCULATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Biomarkers of inflammation predict both vascular and non-vascular mortality in older men
Robert Clarke et al.
EUROPEAN HEART JOURNAL (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Improved estimates of floating absolute risk
M Plummer
STATISTICS IN MEDICINE (2004)
Share Paper
